insights_auto
Zašto je CRSP pao 5,82%?
Istražite detaljnijechevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
54,00 USD
arrow_downward
−5,82%(−3,34) 1D
54,06 USD
arrow_upward
+0,11% (+0,060)bedtimeNakon radnog vremena
Zatvoreno: 6. lis, 16:00:01 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za CRSP...
Otvori
60,38 USD
Najviša
60,68 USD
Najniža
53,74 USD
Trž. kap.
5,05 mlr.
Prosj. kol.
1,52 mil.
Količina
2,63 mil.
52-tjed. najviša
78,48 USD
52-tjed. najniža
44,12 USD
EPS
−4,76 USD
Beta
1,45
Dionice u optjecaju
96,69 mil.
Broj djelatnika
393
Otvori
60,38 USD
Najviša
60,68 USD
Najniža
53,74 USD
Trž. kap.
5,05 mlr.
Prosj. kol.
1,52 mil.
Količina
2,63 mil.
52-tjed. najviša
78,48 USD
52-tjed. najniža
44,12 USD
EPS
−4,76 USD
Beta
1,45
Dionice u optjecaju
96,69 mil.
Broj djelatnika
393
Vijesti
Iz web-izvora i od partnera za vijesti
Zacks
·
prije 1 sat
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
Yahoo Finance
·
prije 2 sata
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
Stock Titan
·
prije 2 sata
Officer James Kasinger proposes selling 1,990 shares of CRISPR Therapeutics (CRSP).
MarketBeat
·
prije 8 sati
CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap Up - Here's What Happened
Profil
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Crispr Therapeutics AG – informacije
Glavni izvršni direktorSamarth Kulkarni
Zaposlenici393
Osnovano2013
SjedišteZug, Zug, Švicarska
Sektor-
Web-lokacijacrisprtx.com